Iomeron Injection, Solution
Product Images NDC 0270-9300

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Iomeron (NDC 0270-9300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bracco Diagnostics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Iomeron 250 Carton 100 mL (Uk Iomeron 250 100ml Box)

This looks like a mix of several texts and symbols, none of which are coherent or in English language. It is not available.*

FDA Label Image

Iomeron 250 Vial 100 mL (Uk Iomeron 250 100ml Label)

FDA Label Image

Iomeron 300 Carton 100 mL (Uk Iomeron 300 100ml Box)

FDA Label Image

Iomeron 300 Vial 100 mL (Uk Iomeron 300 100ml Label)

FDA Label Image

Iomeron 300 Carton 200 mL (Uk Iomeron 300 200ml Box)

FDA Label Image

Iomeron 300 Vial 200 mL (Uk Iomeron 300 200ml Label)

FDA Label Image

Iomeron 300 Carton 500 mL (Uk Iomeron 300 500ml Box)

This appears to be a description of various solutions for injection, including Tomeprol and IOMmeron 300, in multi-dose containers. There are some symbols and characters that are not understandable or recognizable.*

FDA Label Image

Iomeron 300 Vial 500 mL (Uk Iomeron 300 500ml Label)

Iomeron 300 is a solution for injection that comes in a multi-dose container. The active substance of the solution is Iomeprol, which is equivalent to 300mg iodine per milliliter. The container has a volume of 500 ml, and the solution is intended for intravenous use only. The product also contains Trometamol, hydrochloric acid, and water for injections. Users must read the package leaflet before use and store the solution below 30°C, protected from light. The contrast media bottle should only be used with an automatic injector and discarded 10 hours after first opening. The batch number and expiry date are available.*

FDA Label Image

Iomeron 350 Carton 100 mL (Uk Iomeron 350 100ml Box)

FDA Label Image

Iomeron 350 Vial 100 mL (Uk Iomeron 350 100ml Label)

FDA Label Image

Iomeron 350 Carton 200 mL (Uk Iomeron 350 200ml Box)

FDA Label Image

Iomeron 350 Vial 200 mL (Uk Iomeron 350 200ml Label)

FDA Label Image

Iomeron 350 Carton 500 mL (Uk Iomeron 350 500ml Box)

This item is a description of two multi-dose containers of Iomeron 350 solution for injection. The text includes warnings about storage conditions and usage. There is also mention of a package and an automatic injector. The last line indicates that there may be two bottles of 2500 ml each.*

FDA Label Image

Iomeron 350 Vial 500 mL (Uk Iomeron 350 500ml Label)

This is a package of Tomeprol - a solution for injection, multi-dose container which contains lomeprol as an active substance. The product is intended for intravenous use and has a concentration of 714.4 mg of lomeprol per ml. The package contains a bottle of 500mL, which can only be used with an automatic injector. It is essential to read the package leaflet before use and to dispose of the contrast media bottle ten hours after the first opening. The composition includes iodine and other inactive ingredients like Trometamol, hydrochloric acid and water for injections. The batch number and expiry date are mentioned, but the text does not specify what they refer to.*

FDA Label Image

Iomeron 400 Carton 100 mL (Uk Iomeron 400 100ml Box)

FDA Label Image

Iomeron 400 Vial 100 mL (Uk Iomeron 400 100ml Label)

FDA Label Image

Iomeron 400 Carton 200 mL (Uk Iomeron 400 200ml Box)

FDA Label Image

Iomeron 400 Vial 200 mL (Uk Iomeron 400 200ml Label)

FDA Label Image

Iomeron 400 Carton 500 mL (Uk Iomeron 400 500ml Box)

Iomeron 400 is a solution for injection available in a multi-dose container. The text contains information related to packaging, dosage, and solution type.*

FDA Label Image

Iomeron 400 Vial 500 mL (Uk Iomeron 400 500ml Label)

Iomeprol 400 is a solution for injection available in multi-dose containers, with each bottle having a capacity of 500 ml. The active substance in the solution is Iomeprol of strength 816.5 mg/mi, which is equivalent to 400mg of iodine/ml. Apart from the active substance, the injection solution also contains trometamol, hydrochloric acid, and water for injections. The recommended mode of administration is intravenous and usage should be limited to an automatic injector. The product should be away from children and light with storage temperature at or below 30°C. The user should be cautious about first opening the solution bottle and discard it after ten hours of first use. The package bottle comes with Bracco UK Lig manufacturer details, and specific batch and expiry date labeling.*

FDA Label Image

Alberto Spinazzi Signature (Alberto Signature)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.